{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:08:35Z","timestamp":1789096115366,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd005354.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:00:00Z","timestamp":1783987200000}}],"reference-count":211,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005354.pub3","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T10:49:59Z","timestamp":1784026199000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Recombinant follicle-stimulating hormone (rFSH) versus other recombinant or urinary gonadotropins for ovarian stimulation in assisted reproductive technology cycles"],"prefix":"10.1002","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1581-8748","authenticated-orcid":false,"given":"Robbert P","family":"Berkhout","sequence":"additional","affiliation":[{"name":"Obstetrics and Gynaecology; Amsterdam UMC; Amsterdam Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8116-727X","authenticated-orcid":false,"given":"Elena B","family":"Kostova","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine; Amsterdam UMC, University of Amsterdam; Amsterdam Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8263-213X","authenticated-orcid":false,"given":"Madelon","family":"van Wely","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine; Amsterdam UMC, University of Amsterdam; Amsterdam Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,7,14]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD005354.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1093\/humrep\/14.6.1418","article-title":"What are the clinical benefits of recombinant gonadotrophins? Recombinant follicle stimulating hormone","volume":"14","author":"Bergh","year":"1999","journal-title":"Human Reproduction"},{"issue":"5","key":"10.1002\/14651858.CD005354.pub3-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1530\/EC-17-0067","article-title":"Comparative pharmacology of a new recombinant FSH expressed by a human cell line","volume":"6","author":"Koechling","year":"2017","journal-title":"Endocrine Connections"},{"issue":"11","key":"10.1002\/14651858.CD005354.pub3-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/jcph.328","article-title":"Different pharmacokinetic and pharmacodynamic properties of recombinant follicle-stimulating hormone (rFSH) derived from a human cell line compared with rFSH from a non-human cell line","volume":"54","author":"Olsson","year":"2014","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ejogrb.2019.07.032","article-title":"A multicenter, randomized, phase III study comparing the efficacy and safety of follitropin alpha biosimilar and the original follitropin alpha","volume":"241","author":"Barakhoeva","year":"2019","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"3","key":"10.1002\/14651858.CD005354.pub3-BIB0005|cit5","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.rbmo.2022.10.006","article-title":"Comparison of recombinant human FSH biosimilar QL1012 with Gonal-f for ovarian stimulation: a phase-three trial","volume":"46","author":"Hu","year":"2023","journal-title":"Reproductive Biomedicine Online"},{"issue":"6","key":"10.1002\/14651858.CD005354.pub3-BIB0006|cit6","doi-asserted-by":"publisher","first-page":"5951\u201453","DOI":"10.18632\/aging.102919","article-title":"Efficacy and safety of recombinant human follicle-stimulating hormone in patients undergoing in vitro fertilization-embryo transfer","volume":"12","author":"Hu","year":"2020","journal-title":"Aging"},{"issue":"3","key":"10.1002\/14651858.CD005354.pub3-BIB0007|cit7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/j.1447-0756.2007.00529.x","article-title":"Comparison of the efficacy and safety of a new recombinant human follicle-stimulating hormone (DA-3801) with follitropin-alpha (Gonal-F) in women undergoing controlled ovarian hyperstimulation for assisted reproductive technology","volume":"33","author":"Moon","year":"2007","journal-title":"Journal of Obstetrics and Gynaecology Research"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0008|cit8","unstructured":"Multi-centre study to compare efficacy and safety of AFOLIA and Gonal-f in women for assisted reproductive treatment https:\/\/clinicaltrials.gov\/show\/NCT01121666 2010"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0009|cit9","unstructured":"Phase III study comparing efficacy and safety of AFOLIA vs gonal-f RFF in women (35 to 42) undergoing IVF https:\/\/clinicaltrials.gov\/show\/NCT01687712 2012"},{"issue":"4","key":"10.1002\/14651858.CD005354.pub3-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"524","DOI":"10.5935\/1518-0557.20210023","article-title":"Efficacy, safety, and immunogenicity of a biosimilar recombinant human follicle-stimulating hormone (Folitime) vs. Gonal-f in women undergoing ovarian stimulation for IVF: a randomized, multicenter, evaluator-blinded, non-inferiority study","volume":"25","author":"Pasqualini","year":"2021","journal-title":"JBRA Assisted Reproduction"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0011|cit11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12958-015-0135-8","article-title":"Randomized, active-controlled, comparative phase 3 efficacy and safety equivalence trial of Ovaleap R (recombinant human follicle-stimulating hormone) in infertile women using assisted reproduction technology (ART)","volume":"14","author":"Strowitzki","year":"2016","journal-title":"Reproductive Biology and Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD005354.pub3-BIB0012|cit12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005354.pub2","article-title":"Recombinant versus urinary gonadotrophin for ovarian stimulation in assisted reproductive technology cycles","author":"Wely","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD005354.pub3-BIB0013|cit13","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003973","article-title":"Human menopausal gonadotropin versus recombinant follicle stimulation hormone for ovarian stimulation in assisted reproductive cycles","author":"Van Wely","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD005354.pub3-BIB0014|cit14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002810","article-title":"Recombinant versus urinary follicle stimulating hormone for ovarian stimulation in assisted reproduction cycles","author":"Daya","year":"2000","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD005354.pub3-BIB0015|cit15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000061","article-title":"Follicle-stimulating hormone and human menopausal gonadotropin for ovarian stimulation in assisted reproduction cycles","author":"Daya","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD005354.pub3-BIB0016|cit16","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001750.pub4","article-title":"Gonadotrophin-releasing hormone antagonists for assisted reproductive technology","author":"Al-Inany","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD005354.pub3-BIB0017|cit17","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000033.pub3","article-title":"Industry sponsorship and research outcome","author":"Lundh","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0018|cit18","unstructured":"Higgins JP Lasserson T Thomas J Flemyng E Churchill R Methodological Expectations of Cochrane Intervention Reviews. Cochrane: London, Version August 2023 Available from https:\/\/community.cochrane.org\/mecir-manual"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0019|cit19","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2020","journal-title":"BMJ"},{"issue":"12","key":"10.1002\/14651858.CD005354.pub3-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1093\/humrep\/deaa241","article-title":"Developing a core outcome set for future infertility research: an international consensus development study","volume":"35","author":"Duffy","year":"2020","journal-title":"Human Reproduction"},{"issue":"1","key":"10.1002\/14651858.CD005354.pub3-BIB0021|cit21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s41073-023-00130-8","article-title":"Checklist to assess Trustworthiness in RAndomised Controlled Trials (TRACT checklist): concept proposal and pilot","volume":"8","author":"Mol","year":"2023","journal-title":"Research Integrity and Peer Review"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1093\/humrep\/deg133","article-title":"Common statistical errors in the design and analysis of subfertility trials","volume":"18","author":"Vail","year":"2003","journal-title":"Human Reproduction"},{"issue":"7","key":"10.1002\/14651858.CD005354.pub3-BIB0023|cit23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009577.pub3","article-title":"Long-acting FSH versus daily FSH for women undergoing assisted reproduction","author":"Pouwer","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0024|cit24","unstructured":"Lefebvre C Glanville J Briscoe S Featherstone R Littlewood A Chapter 4: Searching for and selecting studies [last updated March 2025]. In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5.1 Cochrane, 2025 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0025|cit25","unstructured":"Covidence Veritas Health Innovation 2024"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0026|cit26","unstructured":"Higgins JP Altman DG Sterne JA Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from https:\/\/www.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0027|cit27","unstructured":"Deeks JJ Higgins JP Altman DG McKenzie JE Veroniki AA Chapter 10: Analysing data and undertaking meta-analyses (last updated November 2024). In: Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.5. Cochrane, 2024 Available from https:\/\/cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0028|cit28","unstructured":"Review Manager (RevMan) The Cochrane Collaboration 2026"},{"issue":"7400","key":"10.1002\/14651858.CD005354.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1136\/bmj.326.7400.1167","article-title":"Pharmaceutical industry sponsorship and research outcome and quality: systematic review","volume":"326","author":"Lexchin","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0031|cit31","unstructured":"GRADEpro GDT McMaster University (developed by Evidence Prime) 2015"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0032|cit32","unstructured":"Ryan R Hill S How to GRADE the quality of the evidence. Cochrane Consumers and Communication Group Available at https:\/\/cccrg.cochrane.org\/author-resources"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0033|cit33","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013 Available from gdt.guidelinedevelopment.org\/app\/handbook\/handbook.html"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0034|cit34","unstructured":"Efficacy and tolerability of human FSH versus recombinant FSH (follitropin alpha) in ICSI https:\/\/clinicaltrials.gov\/show\/NCT00335725 2006"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0035|cit35","unstructured":"Human menopausal gonadotropin (HMG) vs recombinant follicle stimulating hormone (rfsh) in gonadotropin releasing hormone (gnrh) antagonist cycles https:\/\/clinicaltrials.gov\/show\/NCT00669786 2008"},{"issue":"6","key":"10.1002\/14651858.CD005354.pub3-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1016\/j.fertnstert.2010.01.051","article-title":"Prospective, randomized study comparing highly purified urinary follicle-stimulating hormone (FSH) and recombinant FSH for in vitro fertilization\/intracytoplasmic sperm injection in patients with polycystic ovary syndrome","volume":"94","author":"Aboulghar","year":"2010","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0037|cit37","unstructured":"Purified urinary follicle stimulating hormone (FSH) and recombinant FSH follitropin-alpha for polycystic ovarian syndrome (PCOS) patients undergoing intra-cytoplasmic sperm injection (ICSI) https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=ISRCTN36808716"},{"issue":"6","key":"10.1002\/14651858.CD005354.pub3-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/j.fertnstert.2014.08.013","article-title":"Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antim\u00fcllerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization\/intracytoplasmic sperm injection","volume":"102","author":"Arce","year":"2014","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0039|cit39","unstructured":"A randomised, controlled, assessor-blind, parallel groups, multinational, multicentre trial assessing the dose-response relationship of FE 999049 in controlled ovarian stimulation in women undergoing an assisted reproductive technology programme https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2011-000633-36-ES"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0040|cit40","first-page":"i439","article-title":"A multicenter, randomized study comparing the efficacy of follitropin alpha biosimilar and the original follitropin alpha","volume":"34 Suppl 1","author":"Polzikov","year":"2019","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0041|cit41","unstructured":"Study to compare efficacy and safety of primapur and gonal-f in women for assisted reproductive treatment https:\/\/clinicaltrials.gov\/show\/NCT03088137 2017"},{"issue":"1","key":"10.1002\/14651858.CD005354.pub3-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"131","DOI":"10.5935\/1518-0557.20200064","article-title":"Randomized controlled trial comparing embryonic quality in rFSH versus hMG in the IVF protocol with GnRH Antagonist","volume":"25","author":"Chapon","year":"2020","journal-title":"JBRA Assisted Reproduction"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0043|cit43","unstructured":"Randomized controlled trial comparing embryonic quality in rFSH versus HMG in IVF protocol with GnRH antagonist https:\/\/clinicaltrials.gov\/show\/NCT02412904 2013"},{"issue":"3","key":"10.1002\/14651858.CD005354.pub3-BIB0044|cit44","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.fertnstert.2011.12.016","article-title":"A randomized assessor-blind trial comparing highly purified HMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer","volume":"97","author":"Devroey","year":"2012","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD005354.pub3-BIB0045|cit45","first-page":"97","article-title":"Pregnancy outcome following in vitro fertilization-embryo transfer (IVF-ET) in women aged < 37, undergoing ovulation induction with human FSH compared with recombinant FSH: a randomised controlled study","volume":"14","author":"Gholami","year":"2010","journal-title":"European Review for Medical and Pharmacological Sciences"},{"issue":"2","key":"10.1002\/14651858.CD005354.pub3-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.rbmo.2019.09.003","article-title":"Fully human glyco-optimized recombinant FSH (follitropin epsilon) - a randomized, comparator-controlled phase II clinical trial","volume":"40","author":"Griesinger","year":"2020","journal-title":"Reproductive Biomedicine Online"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0047|cit47","unstructured":"Randomized controlled study of comparing follitrope versus gonal-f in Chinese infertility women https:\/\/clinicaltrials.gov\/show\/NCT03506243 2018"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0048|cit48","unstructured":"Efficacy and safety of QL1012 in women for assisted reproductive treatment https:\/\/clinicaltrials.gov\/study\/NCT05149924"},{"issue":"5","key":"10.1002\/14651858.CD005354.pub3-BIB0049|cit49","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.rbmo.2021.01.023","article-title":"Individualized follitropin delta dosing reduces OHSS risk in Japanese IVF\/ICSI patients: a randomized controlled trial","volume":"42","author":"Ishihara","year":"2021","journal-title":"Reproductive Biomedicine Online"},{"issue":"6","key":"10.1002\/14651858.CD005354.pub3-BIB0050|cit50","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.fertnstert.2020.10.059","article-title":"Randomized, assessor-blind, antim\u00fcllerian hormone-stratified, dose-response trial in Japanese in vitro fertilization\/intracytoplasmic sperm injection patients undergoing controlled ovarian stimulation with follitropin delta","volume":"115","author":"Ishihara","year":"2021","journal-title":"Fertility and Sterility"},{"issue":"6","key":"10.1002\/14651858.CD005354.pub3-BIB0051|cit51","first-page":"i444","article-title":"A randomised, assessor-blind, AMH-stratified, doseresponse trial in Japanese IVF\/ICSI patients undergoing controlled ovarian stimulation with follitropin delta","volume":"32","author":"Ishihara","year":"2017","journal-title":"Human Reproduction"},{"issue":"4","key":"10.1002\/14651858.CD005354.pub3-BIB0052|cit52","doi-asserted-by":"publisher","first-page":"385","DOI":"10.22074\/ijfs.2015.4178","article-title":"Efficacy of highly purified urinary FSH versus recombinant FSH in Chinese women over 37 years undergoing assisted reproductive techniques","volume":"8","author":"Liu","year":"2015","journal-title":"International Journal of Fertility and Sterility"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0053|cit53","unstructured":"A study of the efficacy and safety of highly purified menotrophin versus recombinant follitropin alfa https:\/\/clinicaltrials.gov\/show\/NCT00257556 2005"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0054|cit54","unstructured":"A prospective, open label, randomised, parallel group, comparative pilot study to study the efficacy and safety of highly purified Menotrophin versus recombinant FSH (Follitropin alfa) administered subcutaneously to subfertile female patients undergoing IVF using antagonist downregulation. - PROSPECT https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2004-001307-35-GB"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0055|cit55","unstructured":"A randomised, controlled, assessor-blind, parallel groups, multicentre, multinational trial comparing the ovarian response of a starting dose of 15 \u00b5g follitropin delta (REKOVELLE) to a starting dose of 225 IU follitropin alfa (GONAL-F) in conventional regimens in controlled ovarian stimulation in women undergoing an assisted reproductive technology programme https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/search?query=eudract_number:2021-001785-38"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0056|cit56","unstructured":"Assessment of conventional dosing in women undergoing ART with follitropin delta treatment https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2021-001785-38-ES"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0057|cit57","unstructured":"A trial to compare the ovarian response of REKOVELLE and GONAL-F in conventional dosing in women undergoing controlled ovarian stimulation (ADAPT-1) https:\/\/clinicaltrials.gov\/study\/NCT05263388"},{"issue":"2","key":"10.1002\/14651858.CD005354.pub3-BIB0058|cit58","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.fertnstert.2016.10.033","article-title":"Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial","volume":"107","author":"Nyboe Andersen","year":"2017","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0059|cit59","unstructured":"Rasmussen BB Klein BM Helmgaard L Arce JC Low immunogenicity potential of follitropin delta, a recombinant FSH preparation produced from a human cell line: results from phase 3 trials (ESTHER-1 and ESTHER-2) Human Reproduction (Oxford, England) 2016 i376 10.1093\/humrep\/31.Supplement_1.1"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0060|cit60","unstructured":"Evidence-based stimulation trial with human rFSH in Europe and rest of world 1 (ESTHER-1) https:\/\/clinicaltrials.gov\/show\/NCT01956110 2013"},{"issue":"10","key":"10.1002\/14651858.CD005354.pub3-BIB0061|cit61","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1007\/s10815-021-02271-5","article-title":"Pregnancy and neonatal outcomes in fresh and frozen cycles using blastocysts derived from ovarian stimulation with follitropin delta","volume":"38","author":"Havelock","year":"2021","journal-title":"Journal of Assisted Reproduction and Genetics"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0062|cit62","unstructured":"A randomised, controlled, assessor-blind, parallel groups, multicentre, multinational trial comparing the efficacy and safety of FE 999049 with follitropin alfa (GONAL-F) in controlled ovarian stimulation in women undergoing an assisted reproductive technology programme https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2013-001669-17-BE"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0063|cit63","doi-asserted-by":"crossref","unstructured":"Nelson SM La Marca A Garcia-Velasco JA Gothberg M Jonker DM Mannaerts B Impact of body weight on ovarian response after individualized or fixed follicle-stimulating hormone dosing in women undergoing ovarian stimulation for in vitro fertilization Fertility and Sterility. Conference: 75th Scientific Congress of the American Society for Reproductive Medicine, October 12-16, 2019, Philadelphia, Pennsylania 2019 e87 e88","DOI":"10.1016\/j.fertnstert.2019.07.350"},{"issue":"9","key":"10.1002\/14651858.CD005354.pub3-BIB0064|cit64","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1093\/humrep\/deab155","article-title":"A randomised controlled trial to clinically validate follitropin delta in its individualised dosing regimen for ovarian stimulation in Asian IVF\/ICSI patients","volume":"36","author":"Qiao","year":"2021","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"1","key":"10.1002\/14651858.CD005354.pub3-BIB0065|cit65","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12958-022-01016-y","article-title":"Comparative clinical outcome following individualized follitropin delta dosing in Chinese women undergoing ovarian stimulation for in vitro fertilization \/intracytoplasmic sperm injection","volume":"20","author":"Yang","year":"2022","journal-title":"Reproductive Biology and Endocrinology"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0066|cit66","unstructured":"Efficacy and safety of FE 999049 in controlled ovarian stimulation in pan-Asian women https:\/\/clinicaltrials.gov\/show\/NCT03296527 2017"},{"issue":"5","key":"10.1002\/14651858.CD005354.pub3-BIB0067|cit67","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.rbmo.2015.01.005","article-title":"A multi-centre phase 3 study comparing efficacy and safety of Bemfola versus Gonal-f in women undergoing ovarian stimulation for IVF","volume":"30","author":"Rettenbacher","year":"2015","journal-title":"Reproductive Biomedicine Online"},{"issue":"5","key":"10.1002\/14651858.CD005354.pub3-BIB0068|cit68","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/j.fertnstert.2009.10.005","article-title":"Ovarian stimulation protocols based on follicle-stimulating hormone glycosylation pattern: impact on oocyte quality and clinical outcome","volume":"94","author":"Selman","year":"2010","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD005354.pub3-BIB0069|cit69","first-page":"229","article-title":"Comparison of highly purified urinary versus recombinant FSH: Effect on ART outcomes in polycystic ovary syndrome","volume":"10","author":"Sohrabvand","year":"2012","journal-title":"Iranian Journal of Reproductive Medicine"},{"issue":"2","key":"10.1002\/14651858.CD005354.pub3-BIB0070|cit70","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.fertnstert.2020.03.029","article-title":"Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection","volume":"114","author":"Witz","year":"2020","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0071|cit71","unstructured":"MENOPUR in a gonadotropin-releasing hormone (GnRH) antagonist cycle with single-blastocyst transfer in a high responder subject population https:\/\/clinicaltrials.gov\/show\/NCT02554279 2015"},{"issue":"3","key":"10.1002\/14651858.CD005354.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.fertnstert.2017.07.073","article-title":"Highly purified human menotropin (HPHMG) versus recombinant follicle stimulating hormone (RFSH) in high responders undergoing in vitro fertilization (IVF): Megaset-HR trial outcomes","volume":"108","author":"Witz","year":"2017","journal-title":"Fertility and Sterility"},{"issue":"7","key":"10.1002\/14651858.CD005354.pub3-BIB0073|cit73","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3109\/09513590.2011.650742","article-title":"Outcome of in vitro fertilization following stimulation with highly purified hMG or recombinant FSH in downregulated women of advanced reproductive age: a prospective, randomized and controlled trial","volume":"28","author":"Ye","year":"2012","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1093\/humrep\/den220","article-title":"Highly purified HMG versus recombinant FSH in ovarian hyperstimulation with GnRH antagonist - a randomised study","volume":"23","author":"Bosch","year":"2008","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"12","key":"10.1002\/14651858.CD005354.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1093\/humrep\/del284","article-title":"Clinical outcome following stimulation with highly purified HMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial","volume":"21","author":"Andersen","year":"2006","journal-title":"Human Reproduction"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"2404\u201313","DOI":"10.1093\/humrep\/dem221","article-title":"Influence of ovarian stimulation with HP-HMG or recombinant FSH on embryo quality parameters in patients undergoing IVF","volume":"22","author":"Ziebe","year":"2007","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"1","key":"10.1002\/14651858.CD005354.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S1472-6483(10)61726-9","article-title":"Ovarian responses to recombinant FSH or HMG in normogonadotrophic women following pituitary desensitization by a depot GnRH agonist for assisted reproduction","volume":"7","author":"Balasch","year":"2003","journal-title":"Reproductive Biomedicine Online"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0015-0282(02)03250-8","article-title":"Efficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fertilization\/intracytoplasmic sperm injection cycles: a randomized, comparative trial","volume":"78","author":"European and Israeli Study Group on Highly Purified Menotropin versus Recombinant Follicle-Stimulating Hormone (EISG)","year":"2002","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0015-0282(00)01701-5","article-title":"A randomized prospective assessor-blind evaluation of luteinizing hormone dosage and in vitro fertilization outcome","volume":"75","author":"Gordon","year":"2001","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/j.fertnstert.2007.05.039","article-title":"Effectiveness of highly purified human menopausal gonadotropin vs. recombinant follicle-stimulating hormone in first-cycle in vitro fertilization-intracytoplasmic sperm injection patients","volume":"89","author":"Hompes","year":"2007","journal-title":"Fertility and Sterility"},{"issue":"6","key":"10.1002\/14651858.CD005354.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/humrep\/deg252","article-title":"A prospective, randomized, controlled trial comparing highly purified HMG with recombinant FSH in women undergoing ICSI: ovarian response and clinical outcomes","volume":"18","author":"Kilani","year":"2003","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/humrep\/16.2.319","article-title":"HMG is as good as recombinant human FSH in terms of oocyte and embryo quality: a prospective randomized trial","volume":"16","author":"Ng","year":"2001","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"3","key":"10.1002\/14651858.CD005354.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0015-0282(01)01973-2","article-title":"Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: a prospective randomized study","volume":"76","author":"Westergaard","year":"2001","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD005354.pub3-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ejogrb.2004.11.007","article-title":"The effect of HMG and recombinant human FSH on oocyte quality: a randomized single-blind clinical trial","volume":"120","author":"Rashidi","year":"2005","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"2","key":"10.1002\/14651858.CD005354.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0015-0282(00)01696-4","article-title":"Impact of recombinant follicle-stimulating hormone and human menopausal gonadotropins on in vitro fertilization outcome","volume":"75","author":"Strehler","year":"2001","journal-title":"Fertility and Sterility"},{"issue":"11","key":"10.1002\/14651858.CD005354.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1093\/humrep\/13.11.2995","article-title":"A prospective randomized clinical trial comparing recombinant follicle stimulating hormone (Puregon) and human menopausal gonadotrophins (Humegon) in non-down-regulated in-vitro fertilization patients","volume":"13","author":"Jansen","year":"1998","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"12","key":"10.1002\/14651858.CD005354.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1093\/oxfordjournals.humrep.a135866","article-title":"Efficacy and safety of recombinant follicle stimulating hormone (Puregon) in infertile women pituitary-suppressed with triptorelin undergoing in-vitro fertilization: a prospective, randomized, assessor-blind, multicentre trial","volume":"10","author":"Hedon","year":"1995","journal-title":"Human Reproduction"},{"issue":"10","key":"10.1002\/14651858.CD005354.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1093\/oxfordjournals.humrep.a135740","article-title":"A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization","volume":"10","author":"Out","year":"1995","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"1","key":"10.1002\/14651858.CD005354.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0015-0282(16)57300-2","article-title":"Clinical assessment of recombinant human follicle-stimulating hormone in stimulating ovarian follicular development before in vitro fertilization","volume":"63","author":"Recombinant human FSH Study Group (RHFSHG)","year":"1995","journal-title":"Fertility and Sterility"},{"issue":"10","key":"10.1002\/14651858.CD005354.pub3-BIB0090|cit90","first-page":"799","article-title":"Recombinant FSH vs. urinary FSH for ovarian stimulation in in vitro fertilization","volume":"48","author":"Meden-Vrtovec","year":"2003","journal-title":"Journal of Reproductive Medicine"},{"issue":"8","key":"10.1002\/14651858.CD005354.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/09513590902770156","article-title":"Efficacy of recombinant versus human derived follicle stimulating hormone on the oocyte and embryo quality in IVF-ICSI cycles: randomized, controlled, multi-centre trial","volume":"25","author":"Abate","year":"2009","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0092|cit92","unstructured":"Antoine JM De Mouzon J Nicollet B Salle B Urbancsek J Grudzinskas JG Effectiveness and tolerability of hFSH compared to rFSH in ICSI: the European study IBSA Satelite Symposium Abstract, ESHRE, Lyon 2007"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.fertnstert.2008.01.064","article-title":"Clinical efficacy of highly purified urinary FSH versus recombinant FSH in volunteers undergoing controlled ovarian stimulation for in vitro fertilization: a randomized, multicenter, investigator-blind trial","volume":"91","author":"Baker","year":"2009","journal-title":"Fertility and Sterility"},{"issue":"10","key":"10.1002\/14651858.CD005354.pub3-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1093\/humrep\/12.10.2133","article-title":"Recombinant human follicle stimulating hormone (r-hFSH; Gonal-F) versus highly purified urinary FSH (Metrodin HP): results of a randomized comparative study in women undergoing assisted reproductive techniques","volume":"12","author":"Bergh","year":"1997","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"6","key":"10.1002\/14651858.CD005354.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0015-0282(02)03131-X","article-title":"Comparison of the efficacy and safety of a highly purified human follicle-stimulating hormone (Bravelle) and recombinant follitropin-beta for in vitro fertilization: a prospective, randomized study","volume":"77","author":"Dickey","year":"2002","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"63 (http:\/\/www.","DOI":"10.1186\/1477-7827-1-63","article-title":"Highly purified human-derived follicle-stimulating hormone (Bravelle) has equivalent efficacy to follitropin-beta (Follistim) in infertile women undergoing in vitro fertilization","volume":"1","author":"Dickey","year":"2003","journal-title":"Reproductive Biology and Endocrinolology"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0015-0282(03)00113-4","article-title":"Bravelle (highly-purified hFSH) vs. Follistim (rFSH) in IVF: pooled analysis from two prospective, randomized clinical trials","volume":"79 Suppl 2","author":"Dickey","year":"2003","journal-title":"Fertility and Sterility"},{"issue":"3","key":"10.1002\/14651858.CD005354.pub3-BIB0098|cit98","first-page":"64","article-title":"The clinical efficacy of recombinant FSH (r-FSH) as compared to highly purified urinary gonadotrophin (HMG-FD) and the use of a low starting dose of r-FSH in IVF or ICSI. A randomized prospective study","volume":"14","author":"Drakakis","year":"2002","journal-title":"Italian Journal of Gynaecology Obstetrics"},{"issue":"1","key":"10.1002\/14651858.CD005354.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/09513590009167653","article-title":"A prospective and randomized study of ovarian stimulation for ICSI with recombinant FSH versus highly purified urinary FSH","volume":"14","author":"Baruffi","year":"2000","journal-title":"Gynecological Endocrinology"},{"issue":"3","key":"10.1002\/14651858.CD005354.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/humrep\/15.3.520","article-title":"A double-blind, randomized study to compare recombinant human follicle stimulating hormone (FSH; Gonal-F) with highly purified urinary FSH (Metrodin) HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm injection","volume":"15","author":"Frydman","year":"2000","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"1","key":"10.1002\/14651858.CD005354.pub3-BIB0101|cit101","first-page":"43","article-title":"The treatment with recombinant FSH improvement the embryo quality in IVF cycles: a prospective randomiced study","volume":"20","author":"Gallego Pastor","year":"2003","journal-title":"Revista Iberoamericana de Fertilidad y Reproduccion Humana"},{"issue":"10","key":"10.1002\/14651858.CD005354.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1093\/humrep\/14.10.2442","article-title":"A prospective, randomized clinical trial comparing 150 IU recombinant follicle stimulating hormone (Puregon) and 225 IU highly purified urinary follicle stimulating hormone (Metrodin-HP) in a fixed-dose regimen in women undergoing ovarian stimulation","volume":"14","author":"Hoomans","year":"1999","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"5","key":"10.1002\/14651858.CD005354.pub3-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/humrep\/15.5.1021","article-title":"Induction of ovulation in women undergoing assisted reproductive techniques: recombinant human FSH (follitropin alpha) versus highly purified urinary FSH (urofollitropin HP)","volume":"15","author":"Lenton","year":"2000","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"5","key":"10.1002\/14651858.CD005354.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.fertnstert.2005.10.049","article-title":"Urinary follicle-stimulating hormone (FSH) is more effective than recombinant FSH in older women in a controlled randomized study","volume":"85","author":"Mohamed","year":"2006","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD005354.pub3-BIB0105|cit105","first-page":"53","article-title":"Efficacy of recombinant follicle stimulating hormone versus urinary follicle stimulating hormone in in-vitro fertilization: a prospective, randomized, assessor-blind study","volume":"12","author":"Nardo","year":"2000","journal-title":"Italian Journal of Gynaecology and Obstetrics"},{"issue":"8","key":"10.1002\/14651858.CD005354.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1093\/humrep\/15.8.1691","article-title":"Ovarian stimulation during assisted reproduction treatment: a comparison of recombinant and highly purified urinary human FSH. On behalf of The Feronia and Apis study group","volume":"15","author":"Schats","year":"2000","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"5","key":"10.1002\/14651858.CD005354.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0015-0282(02)04202-4","article-title":"Effect of highly purified urinary follicle-stimulating hormone on oocyte and embryo quality","volume":"78","author":"Selman","year":"2002","journal-title":"Fertility Sterility"},{"issue":"9","key":"10.1002\/14651858.CD005354.pub3-BIB0108|cit108","first-page":"733","article-title":"Efficacy of recombinant human follicle-stimulating hormone in improving oocyte quality in assisted reproductive techniques","volume":"49","author":"Cheon","year":"2004","journal-title":"Journal of Reproductive Medicine"},{"issue":"4","key":"10.1002\/14651858.CD005354.pub3-BIB0109|cit109","first-page":"191","article-title":"Comparison of recombinant and urinary follicle-stimulating hormone preparations in short-term gonadotropin releasing hormone agonist protocol for in vitro fertilization-embryo transfer","volume":"18","author":"Hugues","year":"2001","journal-title":"Journal of Assisted Reproductrion and Genetics"},{"issue":"11","key":"10.1002\/14651858.CD005354.pub3-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1093\/humrep\/den288","article-title":"A randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation","volume":"23","author":"Abyholm","year":"2008","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0111|cit111","unstructured":"Alama P Requena A Crespo J Munoz M Ballesteros A Munoz E Efficacy and efficiency of rFSH vs uFSH vs hMG: A randomized trial in 552 egg donors Human Reproduction (Oxford, England) 2010 10.1093\/humrep\/de.25.s1.310"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0112|cit112","unstructured":"Arce JC Klein B Midfollicular gonadotropin dose increases do not appear to change the ovarian response determined by the dose selected at the start of the stimulation Human Reproduction (Oxford, England) 2020 i397 i398"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0113|cit113","doi-asserted-by":"crossref","unstructured":"Arce JC Larsson P Establishing the follitropin delta dose providing comparable ovarian response as 150 IU\/day follitropin alfa for controlled ovarian stimulation Fertility and Sterility 2020 e335 e336 10.1016\/j.fertnstert.2020.08.907","DOI":"10.1016\/j.fertnstert.2020.08.907"},{"issue":"2","key":"10.1002\/14651858.CD005354.pub3-BIB0114|cit114","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1023\/a:1009418017662","article-title":"A randomized prospective cross-over study of highly purified follicle-stimulating hormone and human menopausal gonadotrophin for ovarian hyperstimulation in women aged 37-41 years","volume":"17","author":"Bassil","year":"2000","journal-title":"Journal of Assisted Reproduction and Genetics"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0115|cit115","unstructured":"Boostanfar R Devroey P Oberye J Mannaerts B No difference in the cumulative pregnancy rates or live birth rates when comparing corifollitropin alfa with daily rFSH treatment for COS Human Reproduction (Oxford, England) 2010 i47 Abstract no. O 119"},{"issue":"1","key":"10.1002\/14651858.CD005354.pub3-BIB0116|cit116","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.fertnstert.2015.04.018","article-title":"Large, comparative, randomized double-blind trial confirming noninferiority of pregnancy rates for corifollitropin alfa compared with recombinant follicle-stimulating hormone in a gonadotropin-releasing hormone antagonist controlled ovarian stimulation protocol","volume":"104","author":"Boostanfar","year":"2015","journal-title":"Fertility and Sterility"},{"issue":"2","key":"10.1002\/14651858.CD005354.pub3-BIB0117|cit117","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/humrep\/dead251","article-title":"Serum progesterone is lower in ovarian stimulation with highly purified HMG compared to recombinant FSH owing to a different regulation of follicular steroidogenesis: a randomized controlled trial","volume":"39","author":"Bosch","year":"2024","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0118|cit118","unstructured":"Comparative analysis of hormone variations during ovarian stimulation with two different stimulation drugs https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2015-005762-28-ES"},{"issue":"2","key":"10.1002\/14651858.CD005354.pub3-BIB0119|cit119","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000292318","article-title":"Comparison of efficacy of high-dose pure follicle-stimulating hormone versus human menopausal gonadotropins for in vitro fertilization","volume":"40","author":"Check","year":"1995","journal-title":"Gynecologic and Obstetric Investigation"},{"issue":"11","key":"10.1002\/14651858.CD005354.pub3-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1093\/humrep\/16.11.2473","article-title":"HMG is possibly superior to recombinant FSH for IVF","volume":"16","author":"Check","year":"2001","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0121|cit121","unstructured":"Efficacy of highly purified HMG vs. HMG on pregnancy outcomes in vitro fertilization https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=ChiCTR-OPR-15006204 2015"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0122|cit122","unstructured":"Phase II\/III clinical trial of recombinant human follicle-stimulating hormone -CTP fusion protein injection in patients undergoing assisted reproductive technology (ART) https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=ChiCTR2000038030"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0123|cit123","unstructured":"Comparative study of Recombinant human menopausal gonadotrophin in treatment of infertility https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=CTRI\/2017\/11\/010317 2017"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0124|cit124","unstructured":"A study of hormones in infertile women undergoing IVF https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=CTRI\/2020\/11\/029333 2020"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0125|cit125","unstructured":"Recombinant follicle-stimulating hormone in treatment for infertility https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=CTRI\/2022\/03\/040842 2022"},{"issue":"12","key":"10.1002\/14651858.CD005354.pub3-BIB0126|cit126","first-page":"766","article-title":"[A randomized, controlled trial comparing follicle stimulating hormone (FSH) to human menopausal gonadotropin (hMG) in fertilization in vitro]","volume":"23","author":"Daya","year":"1995","journal-title":"Contraception, Fertilite, Sexualite (1992)"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0127|cit127","unstructured":"Daya S Hmg versus FSH: is there any difference? Proceedings of the 2nd World Conference on Ovulation Induction, Bologna, Italy, 12-13 September 1998 1998 183 92"},{"issue":"1","key":"10.1002\/14651858.CD005354.pub3-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0015-0282(16)53224-5","article-title":"Equivalency of human menopausal gonadotropin and follicle-stimulating hormone stimulation after gondadotropin-releasing hormone agonist suppression","volume":"53","author":"Edelstein","year":"1990","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0129|cit129","unstructured":"Clinical study to compare the safety and effectiveness of Actavis rhFSH (the medicine being developed) with GONAL-f (an approved medicine) in Stimulating Multiple Follicles (a woman's eggs or ova) in Women Participating in an Assisted Reproductive Technology Program (such as in vitro fertilisation, 'IVF') https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2013-003788-67-BE 2014"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0130|cit130","unstructured":"Randomized, single blind, prospective clinical study to compare hFSH-HP (Fostipur) and hMG-HP (Menopur) in patients with polycystic ovary ander a FIV\/ICSI cicle https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2014-005099-27-ES 2015"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0131|cit131","unstructured":"Comparative analysis between recombinant FSH biosimilar vs. urinary FSH in a oocyte donation program https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2015-002214-77-ES"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0132|cit132","unstructured":"Prospective, randomized open trial to evaluate the efficacy of highly purified urinary FSH (fostipur, IBSA) versus recombinant FSH (bemfola finox) in oocyte donors undergoing controlled ovarian stimulation based on receptor N680S FSH gene polymorphism https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2015-003779-31-ES"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0133|cit133","unstructured":"Randomized, single blind, prospective clinical study to compare hFSH-HP (Fostipur) and hMG-HP(Meriofert) in patients with polycystic ovary ander a FIV\/ICSI cicle https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=EUCTR2015-005660-42-ES 2016"},{"issue":"2","key":"10.1002\/14651858.CD005354.pub3-BIB0134|cit134","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/s0015-0282(03)00594-6","article-title":"Comparison of controlled ovarian stimulation with human menopausal gonadotropin or recombinant follicle-stimulating hormone","volume":"80","author":"Filicori","year":"2003","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0135|cit135","doi-asserted-by":"crossref","unstructured":"Frattarelli JL Miller BT Kaplan B Widra E Scott RT Does leutinizing hormone activity in the form of low-dose HCG or HMG produce better outcomes for GnRH antagonist art cycles stimulated with rFSH? Fertility and Sterility 2007 132, Abstract no: 68","DOI":"10.1016\/j.fertnstert.2007.07.423"},{"issue":"7-8","key":"10.1002\/14651858.CD005354.pub3-BIB0136|cit136","first-page":"670","article-title":"Randomized study of pure FSH\/HMG in ovarian stimulation with agonist (long protocol)","volume":"18","author":"Fries","year":"1990","journal-title":"Contraception, Fertilite, Sexualite"},{"issue":"1","key":"10.1002\/14651858.CD005354.pub3-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0015-0282(00)00605-1","article-title":"Subcutaneously administered Repronex in female patients undergoing in vitro fertilization is as effective and well tolerated as intramuscular menotropin treatment Repronex SC, IVF Study Group","volume":"74","author":"Gocial","year":"2000","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD005354.pub3-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/humrep\/14.Suppl_3.320-a","article-title":"Comparison of ovulation induction with rFSH and highly pruified urinary FSH (FSH HP) in IVF","volume":"14","author":"Gomez Parga","year":"1999","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0139|cit139","unstructured":"Hillensjo T Von E A comparison of corifollitropin vs. recombinant FSH in a GnRH antagonist protocol for controlled ovarian stimulation in women weighing 60 kg or less Molecular Human Reproduction 2009 10.1093\/humrep\/dep701"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0140|cit140","doi-asserted-by":"crossref","unstructured":"Irvine R Abdalla H Studd J A prospective randomised study to ascertain if gonadotrophins with differing FSH:LH ratios affect oocyte maturation, fertilisation and outcome in assisted conception cycles XVI FIGO World Congress of O & G Washington DC Sept 3-8 2000 2000 41","DOI":"10.1016\/S0015-0282(00)01175-4"},{"issue":"4","key":"10.1002\/14651858.CD005354.pub3-BIB0141|cit141","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1159\/000064568","article-title":"A prospective comparative study on IVF outcomes with either purified FSH or human menopausal gonadotrophin in downregulated normogonadotrophic women","volume":"53","author":"Ismail","year":"2002","journal-title":"Gynecologic and Obstetric Investigation"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0142|cit142","doi-asserted-by":"crossref","unstructured":"Khair AF Foster ED Sinha A Elci OU Daftary GS Heiser PW Differential ovarian response to gonadotropin preparations despite similar ovarian reserve: Menopur in GnRH (gonadotropin releasing hormone) antagonist single embryo transfer - high responder (MEGASET-HR) trial analysis Fertility and Sterility 2020 e92 10.1016\/j.fertnstert.2020.08.280","DOI":"10.1016\/j.fertnstert.2020.08.280"},{"issue":"Suppl","key":"10.1002\/14651858.CD005354.pub3-BIB0143|cit143","first-page":"44","article-title":"Use of follicle stimulating hormone versus human menopausal gonadotropin in-vitro fertilization","volume":"76","author":"Kontic","year":"1997","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"4","key":"10.1002\/14651858.CD005354.pub3-BIB0144|cit144","doi-asserted-by":"publisher","first-page":"681","DOI":"10.25258\/ijpqa.10.4.21","article-title":"Efficacy of follitropin-a (Gonal-f) versus follitropin-b (puregon) for controlled ovarian stimulation in women undergoing in vitro fertilization (ivf)","volume":"10","author":"Kurji","year":"2019","journal-title":"International Journal of Pharmaceutical Quality Assurance"},{"issue":"1","key":"10.1002\/14651858.CD005354.pub3-BIB0145|cit145","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/s0015-0282(16)60011-0","article-title":"Ovarian stimulation for in vitro fertilization and embryo transfer, human menopausal gonadotropin versus pure human follicle stimulating hormone: a randomized prospective study","volume":"50","author":"Lavy","year":"1988","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.1002\/14651858.CD005354.pub3-BIB0146|cit146","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/s0015-0282(03)02185-x","article-title":"Economic evaluation of highly purified menotropin compared with recombinant follicle-stimulating hormone in assisted reproduction","volume":"80","author":"Lloyd","year":"2003","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0147|cit147","doi-asserted-by":"crossref","unstructured":"Mahmoud K Zhioua F Ben Aribia MH Meherzi F Nemsia J Elouakdi M Does controlled ovarian stimulation (COS) in assisted reproductive technologies with recombined human FSH (r-hFSH) need the use of human menopausal gonadotropin (HMG)? Fertility and Sterility 2001 S235 S236 10.1016\/S0015-0282(01)02700-5","DOI":"10.1016\/S0015-0282(01)02700-5"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0148|cit148","doi-asserted-by":"crossref","unstructured":"Marrs R Check J Schnell V Jacobs M Yemini M Oskowitz S Evaluation of mixed protocols with Bravelle (hFSH) and Repronex (hMG) to assess clinical efficacy (EMBRACE I) in patients (18-33 years) undergoing in vitro fertilization Fertility and Sterility 2003 S14 15, Abstract no: P","DOI":"10.1016\/S0015-0282(03)00106-7"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0149|cit149","doi-asserted-by":"crossref","unstructured":"Marshall D Check C Schnell V Jacobs M Yemini M Oskowitz S A randomized, comparative, 3-arm, parallel group, open-label, multicenter study of the efficacy and safety of Bravelle (purified human FSH) and Repronex when mixed in the same syringe and administered subcutaneously in continuous or sequential dose ratios Fertility and Sterility 2002 S16","DOI":"10.1016\/S0015-0282(02)03038-8"},{"issue":"5","key":"10.1002\/14651858.CD005354.pub3-BIB0150|cit150","first-page":"371","article-title":"[Comparative randomized controlled study between human follicle- stimulating hormone (FSH-HP) and human menopausal gonadotropins (hMG) in in vitro fertilization] [French]","volume":"25","author":"Mayenga","year":"1997","journal-title":"Contraception, Fertilite, Sexualite"},{"issue":"3","key":"10.1002\/14651858.CD005354.pub3-BIB0151|cit151","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.fertnstert.2009.05.005","article-title":"A prospective, randomized, controlled trial comparing three different gonadotropin regimens in oocyte donors: ovarian response, in vitro fertilization outcome, and analysis of cost minimization","volume":"94","author":"Melo","year":"2010","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0152|cit152","first-page":"283","article-title":"Comparison between HP-FSH and HMG for superovulation in women undergoing in vitro fertilization","volume":"20","author":"Miron","year":"1998","journal-title":"Journal of Obstetrics & Gynaecology Canada"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0153|cit153","unstructured":"Mousavi Fatemi H Doody K Witjes H Mannaerts B A high ovarian response does not compromise the chance of pregnancy Human Reproduction (Oxford, England) 2011 10.1093\/humrep\/26.s1.90"},{"issue":"1","key":"10.1002\/14651858.CD005354.pub3-BIB0154|cit154","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1447-0578.2007.00161.x","article-title":"Recombinant-follicle stimulating hormone is more effective than urinary human menopausal gonadotropin in ovarian hyperstimulation for assisted reproductive technology treatment","volume":"6","author":"Nakagawa","year":"2007","journal-title":"Reproductive Medicine and Biology"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0155|cit155","unstructured":"Clinical study of recombinant human follitropin for injection assisted in COH assisted IVF-ET https:\/\/clinicaltrials.gov\/study\/NCT03071172 2017"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0156|cit156","unstructured":"Study on the safety and pharmacokinetics of LM001 and gonal-F\u00ae in healthy women https:\/\/clinicaltrials.gov\/show\/NCT03535103 2018"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0157|cit157","unstructured":"Recombinant follicle-stimulating hormone in treatment for infertility https:\/\/clinicaltrials.gov\/show\/NCT05266924"},{"issue":"6","key":"10.1002\/14651858.CD005354.pub3-BIB0158|cit158","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/humrep\/deg234","article-title":"An open, randomized single-centre study to compare the efficacy and convenience of follitropin beta administered by a pen device with follitropin a administered by a conventional syringe in women undergoing ovarian stimulation for IVF\/ICSI","volume":"18","author":"Platteau","year":"2003","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"3","key":"10.1002\/14651858.CD005354.pub3-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0015-0282(16)59415-1","article-title":"Comparison of urinary human follicle-stimulating hormone and human menopausal gonadotropins for ovarian stimulation in an in in vitro fertilization program","volume":"48","author":"Scoccia","year":"1987","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD005354.pub3-BIB0160|cit160","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s40261-022-01232-9","article-title":"Pharmacokinetics and safety of follitropin delta in gonadotropin down-regulated healthy Chinese women","volume":"43","author":"Shao","year":"2023","journal-title":"Clinical Drug Investigation"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1093\/oxfordjournals.humrep.a019508","article-title":"A randomized comparative study of highly purified follicle stimulating hormone and human menopausal gonadotrophin for ovarian hyperstimulation in an oocyte donation programe","volume":"11","author":"Soderstrom Anttila","year":"1996","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"5","key":"10.1002\/14651858.CD005354.pub3-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S0015-0282(16)53512-2","article-title":"Stimulation with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression in polycystic ovarian syndrome","volume":"53","author":"Tanbo","year":"1990","journal-title":"Fertility and Sterility"},{"issue":"1","key":"10.1002\/14651858.CD005354.pub3-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/humrep\/14.Suppl_3.196","article-title":"Comparison of two recombinant follicle stimulating hormone preparations in in-vitro fertilization treatment: results from a randomized study","volume":"14","author":"Tulppala","year":"1999","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"1","key":"10.1002\/14651858.CD005354.pub3-BIB0164|cit164","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12978-015-0106-8","article-title":"Ovarian stimulation with human and recombinant gonadotropin - Comparison of in vitro fertilization efficiency with use of time-lapse monitoring","volume":"12","author":"Wdowiak","year":"2015","journal-title":"Reproductive Health"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/oxfordjournals.humrep.a019357","article-title":"The effect of human menopausal gonadotrophin and highly purified urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down regulated normogondotrophic woman","volume":"11","author":"Westerguard","year":"1996","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"5","key":"10.1002\/14651858.CD005354.pub3-BIB0166|cit166","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/OGX.0000000000001281","article-title":"Randomized, assessor-blinded trial comparing highly purified human menotropin and recombinant follicle-stimulating hormone in high responders undergoing intracytoplasmic sperm injection","volume":"79","author":"Witz","year":"2024","journal-title":"Obstetrical & Gynecological Survey"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0167|cit167","doi-asserted-by":"publisher","first-page":"ii248","DOI":"10.1093\/humrep\/27.s2.82","article-title":"A randomised open-label trial comparing highly purified hMG and recombinant FSH in a GnRH agonist cycle","volume":"27 Suppl 2","author":"Aydin","year":"2012","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0168|cit168","unstructured":"A trial to compare highly purified human menopausal gonadotropins (hMG) and recombinant follicular stimulating hormone (rFSH) to improve pregnancy rates in infertile women https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=ACTRN12612000294853"},{"issue":"12","key":"10.1002\/14651858.CD005354.pub3-BIB0169|cit169","doi-asserted-by":"publisher","first-page":"1258EP","DOI":"10.3760\/cma.j.cn101441-20240712-00253","article-title":"A phase III follow-up study of recombinant human follicle-stimulating hormone (Follitrope) over 6.5 years","volume":"44","author":"Bu","year":"2024","journal-title":"Chinese Journal of Reproduction and Contraception"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0170|cit170","doi-asserted-by":"crossref","unstructured":"Chen XN Lu GX Yan JM Chen ZJ Xiao HM Chen G An open, prospective, randomized, multicenter study to compare recombinant human follicle stimulating hormone (rec-FSH; follitropin-; Puregon solution) with highly purified urinary FSH (uFSH, urofollitropin (highly purified), Metrodin HP) in Chinese women Fertility and Sterility 2004 S228 10.1016\/j.fertnstert.2004.07.603","DOI":"10.1016\/j.fertnstert.2004.07.603"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0171|cit171","unstructured":"Phase III study to evaluate the efficacy and safety of recombinant human FSH of cadila healthcare limited, India as compared to gonal-F administered subcutaneously in female patients undergoing assisted reproductive technology https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=CTRI\/2016\/10\/007367"},{"issue":"11","key":"10.1002\/14651858.CD005354.pub3-BIB0172|cit172","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.18502\/ijrm.v19i11.9917","article-title":"Comparing a biosimilar follitropin alfa (Cinnal-f) with Gonal-f in women undergoing ovarian stimulation: An RCT","volume":"19","author":"Hossein Rashidi","year":"2021","journal-title":"International Journal of Reproductive Biomedicine"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0173|cit173","doi-asserted-by":"crossref","unstructured":"Liu Y A study comparing the effects of two follicle-stimulating hormones used in assisted reproductive technique Fertility and Sterility 2005 S241","DOI":"10.1016\/j.fertnstert.2005.07.621"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0174|cit174","unstructured":"Mayenga J Belaisch-Allart J Grefenstette I Chouraqui A Serkine AA Abirached F Comparison of in vitro fertilization (IVF) outcomes in patients treated with hMG vs. recombinant FSH in their first IVF cycle Human Reproduction (Oxford, England) 2006 i126"},{"issue":"3-4","key":"10.1002\/14651858.CD005354.pub3-BIB0175|cit175","first-page":"153","article-title":"Clinical comparison of ovarian stimulation and luteal support agents in patients undergoing GnRH antagonist IVF cycles","volume":"58","author":"Miller","year":"2013","journal-title":"Journal of Reproductive Medicine"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0176|cit176","doi-asserted-by":"crossref","unstructured":"Motan T Kiddoo DA Randomised study of clinical pregnancy rates using different gonadotropins in IVF\/ICSI cycles Fertility and Sterility 2011 S175 10.1016\/j.fertnstert.2011.07.682","DOI":"10.1016\/j.fertnstert.2011.07.682"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0177|cit177","unstructured":"Recombinant versus highly purified FSH in polycystic ovary syndrome (PCOS) https:\/\/clinicaltrials.gov\/show\/NCT01337531 2011"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0178|cit178","unstructured":"Evaluation of efficacy and safety of highly purified urofollitropin in Chinese females undergoing an assisted reproductive technology (ART) program https:\/\/clinicaltrials.gov\/show\/NCT01922193 2013"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0179|cit179","doi-asserted-by":"crossref","unstructured":"Fernandez-Ponce A Yell D Gregoire R Drakeley AJ Evaluation of pregnancy and live birth outcomes at the Hewitt Fertility Centre for three newly introduced recombinant gonadotropins when compared to human menopausal gonadotropin Human Reproduction (Oxford, England) 2021 i419","DOI":"10.1093\/humrep\/deab130.619"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0180|cit180","unstructured":"Heiser P Foster E Sinha A Elci O Daftary G Predicted high-responder women diagnosed with oligoovulation may benefit from stimulation with highly purified human menopausal gonadotrophin (HP-hMG) Human Reproduction (Oxford, England) 2020 i6"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0181|cit181","unstructured":"Efficacy and safety of FE 999049 in controlled ovarian stimulation in indian women (IRIS) https:\/\/clinicaltrials.gov\/study\/NCT04773353"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0182|cit182","unstructured":"Comparison of effect of four different protocols for ovarian stimulation including: hFSH, rFSH, HMG, sequential use of hFSH & rFSH on quality of oocyte and embryo https:\/\/trialsearch.who.int\/Trial2.aspx?TrialID=IRCT201408116541N7 2014"},{"issue":"1","key":"10.1002\/14651858.CD005354.pub3-BIB0183|cit183","first-page":"57","article-title":"The effect of four different gonadotropin protocols on oocyte and embryo quality and pregnancy outcomes in IVF\/ICSI cycles; a randomized controlled trial","volume":"42","author":"Parsanezhad","year":"2017","journal-title":"Iranian Journal of Medical Sciences"},{"issue":"1","key":"10.1002\/14651858.CD005354.pub3-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/humrep\/14.Suppl_3.296-a","article-title":"An open, randomized, group-comparative study to investigate the efficacy of uregon versus Metrodin in a fixed dose protocol in fertile subjects undergoing in-vitro fertilization","volume":"14","author":"Soong","year":"1999","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"4","key":"10.1002\/14651858.CD005354.pub3-BIB0185|cit185","first-page":"238","article-title":"Human menopausal gonadotropin versus recombinant FSH in polycystic ovary syndrome patients undergoing in vitro fertilization","volume":"6","author":"Turkcapar","year":"2013","journal-title":"International Journal of Fertility and Sterility"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0186|cit186","unstructured":"Alvino H Norman RJ Matthews CD Recombinant human follicle stimulating hormone (Gonal-F,Serono) compared to urinary follicle stimulating hormone (Metrodin) in IVF cycles: a randomised control study Fertility Society of Australia Australasian Gynaecological Endoscopy Society Conference, Melbourne, Australia. 19-25 November 1995"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0187|cit187","doi-asserted-by":"crossref","unstructured":"Berger E Chabloz P De Quay N Sann A Walton S Germond M An open, randomized, group-comparative bi-centre study comparing recombinant FSH Follitropinum beta 150 IU and highly purified urinary FSH 225 IU as a fixed dose regimen in IVF\/ICSI treatment Human Reproduction (Oxford, England) 1999 61 2","DOI":"10.1093\/humrep\/14.Suppl_3.61-a"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0188|cit188","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S0303-7207(99)00225-7","article-title":"Female poor responders","volume":"161","author":"Ferraretti","year":"2000","journal-title":"Molecular and Cellular Endocrinology"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0189|cit189","unstructured":"Ferraretti AP Gianaroli L Magli MC Bafaro G Colacurci N Recombinant FSH versus urinary FSH in non-down regulated poorly responding patients Abstract Book, 11th World Congress of in Vitro Fertilization and Human Reproductive Genetics 1999"},{"issue":"Special Issue","key":"10.1002\/14651858.CD005354.pub3-BIB0190|cit190","first-page":"Abstract O","article-title":"Recombinant versus highly purified urinary FSH to induce ovulation induction and pregnancies in women over 35 years in an IVF\/ICSI programme","volume":"15","author":"Germond","year":"2000","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0191|cit191","unstructured":"Ghosh S Chattopadhyay R Goswami S Chakravarty BN Recombinant FSH versus highly purified urinary FSH - our experience In Abstract Book, 11th World Congress of in Vitro Fertilization and Human Reproductive Genetics 1999"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0192|cit192","doi-asserted-by":"crossref","unstructured":"Chakravarty B Chattopadhyay R Ghosh S Goswami SK Kabir SN Randomized comparative study of recombinant versus highly purified urinary follicle stimulating hormone in controlled ovarian stimulation: our experience International Journal of Obstetrics and Gynecology 2000 suppl 4:40 (FC4 11.03)","DOI":"10.1016\/S0020-7292(00)81782-8"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0193|cit193","unstructured":"Kornilov NV Shlykova SA Loginova JA Tomas C Ashorn RG Comparison of four different gonadotropins for ovarian stimulation in IVF treatment In Vitro Fertilization and Human Reproductive Genetics, 11th World Congress, Bologona, Italy 1999 Abstract book: 379 83"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0194|cit194","first-page":"37, Abstract FC","article-title":"Highly purified gonadotropin and recombinant gonadotropin: study in IVF cycles","volume":"13, supplement","author":"Machado","year":"1999","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0195|cit195","unstructured":"O\u2019Dea L Loumaye E Liu H A randomized, comparative, multicenter clinical trial of recombinant and urinary human FSH in in vitro fertilization and embryo transfer (IVFET) American Fertility Society and The Canadian Fertility and Andrology Society 1993 Annual Meeting, Program Supplement 1993 S50 S51, abstract O-106"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0196|cit196","unstructured":"Larizgoitia I Estrada MD Garcia-Altes A Recombinant FSH as adjuvant in assisted reproduction: some data on the efficacy and efficiency of recombinant FSH urinary FSH Barcelona, Spain: Catalan Agency for Health Technology Assessment and Research (CAHTA) 2000 1 16"},{"issue":"4","key":"10.1002\/14651858.CD005354.pub3-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/S0015-0282(01)03246-0","article-title":"Updated meta-analysis of recombinant follicle-stimulating hormone (FSH) versus urinary FSH for ovarian stimulation in assisted reproduction","volume":"77","author":"Daya","year":"2002","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.1002\/14651858.CD005354.pub3-BIB0198|cit198","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S0015-0282(03)02187-3","article-title":"Effectiveness of human menopausal gonadotropin versus recombinant follicle-stimulating hormone for controlled ovarian hyperstimulation in assisted reproductive cycles: a meta-analysis","volume":"80","author":"Van Wely","year":"2003","journal-title":"Fertility and Sterility"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1472-6483(10)60559-7","article-title":"Efficacy and safety of human menopausal gonadotrophins versus recombinant FSH: a meta-analysis","volume":"16","author":"Al-Inany","year":"2008","journal-title":"Reproductive Biomedicine Online"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1080\/09513590802630120","article-title":"Highly purified HMG achieves better pregnancy rates in IVF cycles but not ICSI cycles compared with recombinant FSH: a meta-analysis","volume":"25","author":"Al-Inany","year":"2009","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD005354.pub3-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/humrep\/dem305","article-title":"Urinary HMG versus recombinant FSH for controlled ovarian hyperstimulation following an agonist long down-regulation protocol in IVF or ICSI treatment: a systematic review and meta-analysis","volume":"23","author":"Coomarasamy","year":"2008","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"2","key":"10.1002\/14651858.CD005354.pub3-BIB0202|cit202","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1159\/000308458","article-title":"Clinical efficacy of highly purified HMG versus recombinant FSH in IVF\/ICSI cycles: a meta-analysis","volume":"70","author":"Jee","year":"2010","journal-title":"Gynecologic and Obstetric Investigation"},{"issue":"6","key":"10.1002\/14651858.CD005354.pub3-BIB0203|cit203","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3109\/09513590.2012.758703","article-title":"Clinical efficacy and cost-effectiveness of HP-human FSH (Fostimon) versus rFSH (Gonal-F) in IVF-ICSI cycles: a meta-analysis","volume":"29","author":"Gerli","year":"2013","journal-title":"Gynecological Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD005354.pub3-BIB0204|cit204","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3109\/09513590.2011.569612","article-title":"Are all human-derived follicle-stimulating hormone products the same? A systematic review and meta-analysis using direct and adjusted indirect analyses, to determine whether Fostimon is more efficient than Metrodin-HP","volume":"28","author":"Al-Inany","year":"2012","journal-title":"Gynecological Endocrinology"},{"issue":"2","key":"10.1002\/14651858.CD005354.pub3-BIB0205|cit205","doi-asserted-by":"publisher","first-page":"hoaa009","DOI":"10.1093\/hropen\/hoaa009","article-title":"ESHRE guideline: ovarian stimulation for IVF\/ICSI","volume":"2020","author":"Ata","year":"2020","journal-title":"Human Reproduction Open"},{"issue":"3","key":"10.1002\/14651858.CD005354.pub3-BIB0206|cit206","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.fertnstert.2024.05.143","article-title":"Individualized dosing of follitropin delta affects live birth and safety in in vitro fertilization treatment: an individual participant data meta-analysis of randomized controlled trials","volume":"122","author":"Nelson","year":"2024","journal-title":"Fertility and Sterility"},{"issue":"7","key":"10.1002\/14651858.CD005354.pub3-BIB0207|cit207","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1007\/s10815-024-03146-1","article-title":"The pregnancy outcomes among women receiving individualized algorithm dosing with follitropin delta: a systematic review of randomized controlled trials","volume":"41","author":"Doroftei","year":"2024","journal-title":"Journal of Assisted Reproduction and Genetics"},{"issue":"1","key":"10.1002\/14651858.CD005354.pub3-BIB0208|cit208","doi-asserted-by":"publisher","first-page":"e12573","DOI":"10.1002\/rmb2.12573","article-title":"Efficacy and safety of follitropin delta versus follitropin alpha\/beta in infertility treatment: a systematic review and meta-analysis","volume":"23","author":"Komiya","year":"2024","journal-title":"Reproductive Medicine and Biology"},{"issue":"1","key":"10.1002\/14651858.CD005354.pub3-BIB0209|cit209","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13048-024-01372-w","article-title":"Efficacy and safety of follitropin delta for ovarian stimulation in vitro fertilization\/ intracytoplasmic sperm injection cycles: a systematic review with meta-analysis","volume":"17","author":"Palomba","year":"2024","journal-title":"Journal of Ovarian Research"},{"issue":"2","key":"10.1002\/14651858.CD005354.pub3-BIB0210|cit210","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1093\/humrep\/deae274","article-title":"Biosimilars versus the originator of follitropin alfa for ovarian stimulation in ART: a systematic review and meta-analysis","volume":"40","author":"Kiose","year":"2025","journal-title":"Human Reproduction"},{"issue":"3","key":"10.1002\/14651858.CD005354.pub3-BIB0211|cit211","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005354","article-title":"Recombinant versus urinary derived gonadotrophins for ovarian stimulation in in vitro fertilisation and intra-cytoplasmic sperm injection cycles","author":"Van Wely","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:18:59Z","timestamp":1789093139000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005354.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Central Editorial Service","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":211,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005354.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,14]]}}}